thyssenkrupp nucera AG & Co KgaA
OTC:THYKF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
thyssenkrupp nucera AG & Co KgaA
OTC:THYKF
|
DE |
|
Novozymes A/S
CSE:NSIS B
|
DK |
thyssenkrupp nucera AG & Co KgaA
thyssenkrupp nucera is an industrial equipment company that designs and builds electrolysis systems. Its main products are large plants for making green hydrogen from water and electricity, and chlor-alkali systems used to produce chlorine and caustic soda for the chemical industry. It sells this equipment to industrial customers that need these materials for fuels, chemicals, steel, refining, and other heavy processes. The company makes money by supplying complete plants, engineering services, key equipment, and long-term support for installation, commissioning, and maintenance. In practice, it acts as a technology provider and project partner, helping customers design and build the core production units for very energy-intensive chemical processes. Its revenue comes mainly from large project contracts and related service work. What makes its business different is that it sits at the center of two specialized industrial markets. One is the long-established chlor-alkali business, where customers need reliable process technology for essential chemicals. The other is green hydrogen, where customers want electrolysis systems that turn renewable power into a cleaner industrial feedstock. That gives the company a role as a builder of critical process technology rather than a mass manufacturer of consumer products.
thyssenkrupp nucera is an industrial equipment company that designs and builds electrolysis systems. Its main products are large plants for making green hydrogen from water and electricity, and chlor-alkali systems used to produce chlorine and caustic soda for the chemical industry. It sells this equipment to industrial customers that need these materials for fuels, chemicals, steel, refining, and other heavy processes.
The company makes money by supplying complete plants, engineering services, key equipment, and long-term support for installation, commissioning, and maintenance. In practice, it acts as a technology provider and project partner, helping customers design and build the core production units for very energy-intensive chemical processes. Its revenue comes mainly from large project contracts and related service work.
What makes its business different is that it sits at the center of two specialized industrial markets. One is the long-established chlor-alkali business, where customers need reliable process technology for essential chemicals. The other is green hydrogen, where customers want electrolysis systems that turn renewable power into a cleaner industrial feedstock. That gives the company a role as a builder of critical process technology rather than a mass manufacturer of consumer products.
Record orders: thyssenkrupp nucera posted second-quarter order intake of EUR 316 million, its highest quarterly level since the IPO, driven by a 300-megawatt Moeve project in Spain and a large Chlor-Alkali order in the Middle East.
Near-term pressure: Sales and EBIT were hit by one-time, largely technical cost effects in green hydrogen, which management said reduced second-quarter performance but should not spill into the second half of the year.
Guidance confirmed: The company kept its full-year outlook unchanged and said it is confident on reaching the lower end of order intake guidance.
Backlog and visibility: Order backlog rose to EUR 732 million, giving the company better visibility for upcoming quarters, while about 3.5 gigawatts of green hydrogen projects remain under execution.
Cost actions: Management launched a cost containment program expected to deliver more than EUR 25 million of annual savings, plus an additional EUR 50 million-plus from broader structural measures.
Service opportunity: Management highlighted a large long-term service opportunity in green hydrogen, estimating more than EUR 2 billion of potential revenue over 25 years from the 3.5 gigawatts currently under execution.
